PCH Holdings PLCPCHH.N0000:CSE

2.50
0.10 / 3.85 %
580.00k
177.78%
--
Close in LKRToday's changeShares traded1 year changeBeta
Data delayed at least 20 minutes, as of Feb 27 2015 08:59 GMT.

About the company

----20083.60k
Revenue in LKR (TTM)Net income in LKRIncorporatedEmployees
IndustryPharmaceuticals & BiotechnologyLocation
PCH Holdings PLC
Level 5, No.451, Galle Road, Colombo 03
COLOMBO03
Sri Lanka
LKA
Phone+94 114724242Fax+94 114724343Websitehttp://www.pchholdings.com
PCH HOLDINGS LIMITED is a holding company. The Company operates its businesses primarily through pharmaceuticals, apparel manufacturing, activated carbons manufacturing, engineering and human resource services. Through its holding subsidiaries, the Company provides medicines, glucose monitoring systems, medical disposals, medical homecare apparatus, anti-cancer pharmaceuticals, biological products, outerwear, casual wear, sportswear, activated carbons, infrastructure and engineering services, as well as electronic security solutions and services, among others. Effective August 30, 2013, Adam Investments Ltd acquired a 20.8% interest in PCH Holdings Ltd.

Mergers & acquisitions

There are no recent mergers or acquisitions for PCH Holdings PLC.
Data delayed at least 20 minutes, as of Feb 27 2015 08:59 GMT.

Peer analysis

Company Revenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings
(TTM)
Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excluding
extraordinary items (TTM)
EPS (including
extraordinary items) (TTM)
Revenue per
share (TTM)
Book value per
share (MRQ)
Asset turnover
(TTM)
Inventory turnover
(TTM)
Receivables turnover
(TTM)
Revenues per
employee (TTM)
Return on
average
assets
(TTM)
Return on
average
assets
(5 yr average)
Return on
investment
(TTM)
Return on
investment
(5 yr average)
Gross margin (TTM)Gross margin (5 yr average)Net profit margin (TTM)Net Profit margin (5 Yr Average)Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio (5 yr average)Revenue
(Year-over-year change%)
Revenue
(5 yr growth rate)
Net income
(Year-over-year change%)
Net income
(5 Yr growth rate)
Capital
expenditure
(5 Yr growth rate)
Dividend
(5 yr growth rate)
Prescient Therapeutics Ltd
842.50k-134.23m573.29m3--1.05--680.46-0.0744-0.07440.00030.10920.0031--0.1284---49.1272-602.6028-51.5988-602.6028-----15,932.31-345.9286----0.00-----58.1752-172.5741------
Tyson Bioresearch, Inc.
719.79m-262.52m711.54m125--1.08--0.9886-1.7672-1.76724.854.420.71954.338.13---26.2419-9.334-32.7606-9.334-8.698410.68-36.4714-16.05991.67--0.00---5.8548-1.990525.46--55.79--
Smruthi Organics Ltd
1.66bn-184.39m503.62m--------0.3026-22.4085-22.4085202.29------------10.12--10.1223.3119.92-11.07783.43---0.2547--16.25-49.00084.31-196.8395---12.6918--
Mangalam Drugs and Organics Limited
3.84bn141.12m530.09m5293.76--2.330.13814.974.97135.04-------------3.0709---3.070930.9120.673.68-1.6903--1.11-----2.34633.6274.24---26.3077--
Aarey Drugs and Pharmaceuticals Ltd
3.86bn18.36m549.43m--29.92--18.000.14250.50640.5064106.34------------2.89--2.892.721.960.47620.5845--0.7405--0.0015.9148.6459.666.3210.11--
Syncom Healthcare Limited
3.00bn72.17m582.34m4128.070.14744.770.19430.83650.836536.4545.810.6419--1.69--1.551.151.761.1518.7016.682.411.363.132.680.109---5.770426.30-208.6624--79.63--
Jupiter Bioscience Ltd
----587.48m----------------------------5.61--5.61--61.37--17.32------10.4842.4329.3020.9222.8255.40-16.7447
Alpa Laboratories Limited
1.32bn-131.79m589.94m------6.020.446-2.904-2.90429.15-------------1.4318---1.431831.5820.76-3.158-2.1136---0.4725----1.07-14.1699-18.0155--35.46--
Vista Pharmaceuticals Ltd
250.28m22.99m616.95m--26.832.9614.962.470.71070.71077.746.430.68227.233.05--6.27-4.418811.53-4.418837.1324.839.19-10.66190.73887.340.00--11.1535.42479.61---60.6588--
Gennex Laboratories Ltd
702.28m6.33m695.75m--109.87--27.250.99070.02320.02322.57------------0.6542--0.654224.0223.730.90170.7089--2.26----16.9217.661.576.0433.61--
Krebs Biochemicals And Industries Ltd
0-37.57m752.34m529---------1.8355-1.83550.00-----------------------------143.3524----------------
Span Diagnostics Ltd
2.29bn-110.16m756.40m523--1.4910.590.3298-7.0264-7.0264146.1732.271.222.577.20---4.03263.65-8.82643.6558.9449.34-3.31752.040.379-0.10250.542632.74-0.40714.10-2,120.243--5.14--
AdMeTech Co Ltd
20.42m-87.40m583.64m3--4.76--28.58-37.4494-37.44948.7932.580.15751.4122.65---67.4071---84.0338--36.50---427.9841--8.72-98.85790.251--8.86---333.4763------
PCH Holdings PLC
----630.00m3.60k--0.3991----------6.26------------------------0.8643--0.4145--97.61--2,977.35------
Agalawatte Plantation Limited
2.27bn-47.91m637.50m7.74k--0.58965.700.2807-1.9164-1.916490.8443.250.51228.133.17---1.08052.87-1.74052.8712.7715.81-2.10962.880.53140.68310.636353.21-9.77552.77-89.7808-28.8887-21.5411--
Pyridam Farma Tbk PT
2.25bn44.58m754.03m79616.910.77714.840.33498.108.10409.09176.291.302.626.36315,868,4002.575.313.385.3163.3365.771.983.110.9451.560.34330.008.9510.0016.7221.8340.99--
Data as of Mar 01 2015. Currency figures normalised to PCH Holdings PLC's reporting currency: Sri Lankan Rupee LKR.
Data delayed at least 20 minutes, as of Mar 02 2015 00:09 GMT.

Institutional shareholders

There are no institutional shareholders for PCH Holdings PLC.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.